Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dually response.

Hu X, Hao X, Wu Y, Zhang J, Zhang X, Wang PC, Zou G, Liang XJ.

J Mater Chem B Mater Biol Med. 2013;1(8):1109-1118. Epub 2012 Dec 13.

2.

Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.

Zou Z, He D, He X, Wang K, Yang X, Qing Z, Zhou Q.

Langmuir. 2013 Oct 15;29(41):12804-10. doi: 10.1021/la4022646. Epub 2013 Oct 3.

PMID:
24073830
3.

Encapsulating magnetic and fluorescent mesoporous silica into thermosensitive chitosan microspheres for cell imaging and controlled drug release in vitro.

Gui R, Wang Y, Sun J.

Colloids Surf B Biointerfaces. 2014 Jan 1;113:1-9. doi: 10.1016/j.colsurfb.2013.08.015. Epub 2013 Sep 1.

PMID:
24060924
4.

pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.

Zheng J, Tian X, Sun Y, Lu D, Yang W.

Int J Pharm. 2013 Jun 25;450(1-2):296-303. doi: 10.1016/j.ijpharm.2013.04.014. Epub 2013 Apr 15.

PMID:
23598077
5.

One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma.

Li ZY, Liu Y, Wang XQ, Liu LH, Hu JJ, Luo GF, Chen WH, Rong L, Zhang XZ.

ACS Appl Mater Interfaces. 2013 Aug 28;5(16):7995-8001. doi: 10.1021/am402082d. Epub 2013 Aug 2.

PMID:
23869943
6.

Mesoporous Silica Nanoparticles Coated by Layer-by-Layer Self-assembly Using Cucurbit[7]uril for in Vitro and in Vivo Anticancer Drug Release.

Li QL, Sun Y, Sun YL, Wen J, Zhou Y, Bing QM, Isaacs LD, Jin Y, Gao H, Yang YW.

Chem Mater. 2014 Nov 25;26(22):6418-6431. Epub 2014 Oct 20.

7.

Reduction-responsive drug delivery based on mesoporous silica nanoparticle core with crosslinked poly(acrylic acid) shell.

Li H, Zhang JZ, Tang Q, Du M, Hu J, Yang D.

Mater Sci Eng C Mater Biol Appl. 2013 Aug 1;33(6):3426-31. doi: 10.1016/j.msec.2013.04.033. Epub 2013 Apr 22.

PMID:
23706230
8.

Hybrid nanoparticles for drug delivery and bioimaging: mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye.

Xie M, Shi H, Ma K, Shen H, Li B, Shen S, Wang X, Jin Y.

J Colloid Interface Sci. 2013 Apr 1;395:306-14. doi: 10.1016/j.jcis.2013.01.001. Epub 2013 Jan 10.

PMID:
23394807
9.

Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.

Gao Y, Chen Y, Ji X, He X, Yin Q, Zhang Z, Shi J, Li Y.

ACS Nano. 2011 Dec 27;5(12):9788-98. doi: 10.1021/nn2033105. Epub 2011 Nov 16.

PMID:
22070571
10.

Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.

Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S.

Nanotechnology. 2011 Nov 11;22(45):455102. doi: 10.1088/0957-4484/22/45/455102. Epub 2011 Oct 21.

PMID:
22019849
11.

Designed fabrication of unique eccentric mesoporous silica nanocluster-based core-shell nanostructures for pH-responsive drug delivery.

Chen L, Li L, Zhang L, Xing S, Wang T, Wang YA, Wang C, Su Z.

ACS Appl Mater Interfaces. 2013 Aug 14;5(15):7282-90. doi: 10.1021/am401627u. Epub 2013 Jul 17.

PMID:
23808730
12.

Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance.

Huang IP, Sun SP, Cheng SH, Lee CH, Wu CY, Yang CS, Lo LW, Lai YK.

Mol Cancer Ther. 2011 May;10(5):761-9. doi: 10.1158/1535-7163.MCT-10-0884. Epub 2011 Mar 16.

13.

A novel thermal and pH responsive drug delivery system based on ZnO@PNIPAM hybrid nanoparticles.

Tan L, Liu J, Zhou W, Wei J, Peng Z.

Mater Sci Eng C Mater Biol Appl. 2014 Dec;45:524-9. doi: 10.1016/j.msec.2014.09.031. Epub 2014 Sep 18.

PMID:
25491860
14.

Facile strategy for synthesis of silica/polymer hybrid hollow nanoparticles with channels.

Wu C, Wang X, Zhao L, Gao Y, Ma R, An Y, Shi L.

Langmuir. 2010 Dec 7;26(23):18503-7. doi: 10.1021/la103629v. Epub 2010 Nov 9.

PMID:
21062000
15.

Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.

Li J, Du X, Zheng N, Xu L, Xu J, Li S.

Colloids Surf B Biointerfaces. 2016 May 1;141:374-81. doi: 10.1016/j.colsurfb.2016.02.009. Epub 2016 Feb 6.

PMID:
26878288
16.

Poly(N-isopropylacrylamide)-gated Fe3O4/SiO2 core shell nanoparticles with expanded mesoporous structures for the temperature triggered release of lysozyme.

Yu E, Galiana I, Martínez-Máñez R, Stroeve P, Marcos MD, Aznar E, Sancenón F, Murguía JR, Amorós P.

Colloids Surf B Biointerfaces. 2015 Nov 1;135:652-60. doi: 10.1016/j.colsurfb.2015.06.048. Epub 2015 Jul 22.

PMID:
26335056
17.

Chondroitin sulfate functionalized mesostructured silica nanoparticles as biocompatible carriers for drug delivery.

Xi J, Qin J, Fan L.

Int J Nanomedicine. 2012;7:5235-47. doi: 10.2147/IJN.S34128. Epub 2012 Oct 9.

18.

A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.

He Q, Gao Y, Zhang L, Zhang Z, Gao F, Ji X, Li Y, Shi J.

Biomaterials. 2011 Oct;32(30):7711-20. doi: 10.1016/j.biomaterials.2011.06.066. Epub 2011 Aug 4.

PMID:
21816467
19.

Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.

Pan YJ, Chen YY, Wang DR, Wei C, Guo J, Lu DR, Chu CC, Wang CC.

Biomaterials. 2012 Sep;33(27):6570-9. doi: 10.1016/j.biomaterials.2012.05.062. Epub 2012 Jun 15.

PMID:
22704845
20.

Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery.

Yuan H, Bao X, Du YZ, You J, Hu FQ.

Int J Nanomedicine. 2012;7:5119-28. doi: 10.2147/IJN.S35575. Epub 2012 Sep 26.

Items per page

Supplemental Content

Write to the Help Desk